Deep Dive

Patients
Time for a new model in patient access

Time for a new model in patient access

Mig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is defined as we enter a new technological era for medicines.

Patients
Patients want to be heard. Is pharma listening?

Patients want to be heard. Is pharma listening?

A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.